Universal Medical Announces 2021 Annual Results: Business with Steady Promotion, Net Profit of Hospital...
Genertec Universal Medical Group Company Limited (the Company or Universal Medical, and together with its subsidiaries, the Group; HKG: 2666) is pleased to announce...
Kindstar Globalgene Announces FY2021 Annual Results, Revenue Increases to RMB930.67 Million
Focuses on Specialty Esoteric Testing Business
Optimizes Vertical and Horizontal Industry Chain Deployment
Kindstar Globalgene Technology, Inc. (Kindstar Globalgene or the Company, together with...
Angelalign Announces 2021 Annual Results
Continuously penetrate the digital orthodontics to optimize treatment experience
Steady growth in revenue and profit
Angelalign Technology Inc (Angelalign or Company; HKG: 6699) was...
Kingworld Medicines Group Issues Positive Profit Alert for 2021
Kingworld Medicines Group Limited (HKG: 1110), a leading omni-channel enterprise providing greater health products and services in China, issued today a positive profit alert...
Essex Bio-Technology Announces 2021 Financial Results
Achieves an increase of 58% in Profit-After-Tax to HK$346.0 million and Turnover Growth of 67.4% to HK$1,637.7 million
Essex Bio-Technology Ltd (Essex or the...
Recbio Announces Proposed Listing on the Main Board of the Hong Kong Stock Exchange
Offer Price of HK $24.80 per H Share, To Raise Proceeds Up to HK$765 Million
Focus on the R&D of HPV Vaccine Candidates,...
Sisram Medical Ltd Announces 2021 Record Annual Results
Strong Performance Led by Synergistic Development of Four Main Business Lines Under One Ecosystem
Sisram Medical Ltd (the Company or Sisram, HKG: 1696; together with...
Hua Medicine Announces 2021 Annual Results
Dorzagliatin Commercialization Preparations are Finalized
Actively Advancing Full-Life-Cycle Management Plans of Drugs
Hua Medicine (the Company, HKG: 2552) today announces the audited annual results...
IND Application for SinoMab’s First-in-Class Asthma Therapeutic Product SM17 Approved by FDA
SinoMab BioScience Limited (SinoMab or the Company, together with its subsidiaries, the Group, HKG: 3681), a Hong Kong-based biopharmaceutical company dedicated to the research,...
Jacobson Pharma’s Chairman Uplifts Shareholding to Above 60%
Mr. Derek Sum, Chairman and Chief Executive Officer of Jacobson Pharma Corporation Limited (the Company; together with its subsidiaries, the Group; HKG: 2633), a...
Resintech Bhd Acquires 30% stake in Bionutricia for RM8.7 Million
Company sees growth from use of plant and fruit extracts for food supplement and healthcare products
Resintech Berhad (Bursa: RESINTC, 7232), a fully integrated provider...
EC Healthcare’s Chairman Eddy Tang Further Increases Shareholdings With Strong Confidence in the Group’s...
EC Healthcare (the Company, which together with its subsidiaries is referred to as the Group, HKG: 2138), the largest non-hospital medical group in Hong...
EC Healthcare Launch Tele-Medicine and Drug Delivery Service, Reduce Infection Risk and Protect Citizen’s...
EC Healthcare (the Company, which together with its subsidiaries is referred to as the Group, HKG: 2138), the largest non-hospital medical group in Hong...
CT Event Asia to host 2nd Annual Future Hospital Strategy and Development Forum 2022
This year, CT Event Asia is all set to bring you the 2nd Annual Future Hospital Strategy and Development Forum 2022, themed "The Future...
EC Healthcare Included as an Eligible Stock of the Shenzhen – Hong Kong Stock...
EC Healthcare (the Company, which together with its subsidiaries is referred to as the Group, HKG: 2138), the largest non-hospital medical group in Hong...
EC Healthcare and ClinicONE jointly launch A.I. Remote Nursing Program
EC Healthcare and ClinicONE jointly launched the intelligent remote health management platform Health.Me2 today. Through IoT cloud technology with A.I. medical analysis and professional...
Altamira Therapeutics and Nuance Pharma Enter Into Exclusive Licensing and Distribution Agreement for Bentrio...
Nuance Pharma to develop and commercialize Bentrio(TM) nasal spray in Chinese Mainland, Hong Kong, Macau and South Korea
Altamira to receive up to...
Oculis Strengthens Leading Ophthalmology Pipeline by In-Licensing Neuroprotective Drug Candidate for Glaucoma from Accure...
First-in-class peptidomimetic with distinct MoA activating trophic signaling pathways to protect and prevent damage to the optic nerve and retina
Potential to be...
Avance Clinical Announces New Office Opening in Sydney
Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has opened new offices in Sydney to support its growing clinical...
Senior Management Further Increases Shareholdings in EC Healthcare With Strong Confidence in the Group’s...
EC Healthcare (the Company, which together with its subsidiaries is referred to as the Group, HKG: 2138), the largest non-hospital medical group in Hong...
